rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Matthew McDonnell

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Anteris Technologies Global.

In numbers

Trades disclosed
19
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
16 Dec 2024
Last trade
5 Jun 2026
Last filed
9 Jun 2026

Companies traded

Where they are an officer
AVR Anteris Technologies GlobalOfficer · Medical Devices · last 5 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
5 Jun 2026filed 9 Jun 2026AVR Anteris Technologies GlobalMedical DevicesSEC FORM 4 Code M$9,6852,001 at $4.84filing
5 Jun 2026filed 9 Jun 2026AVR Anteris Technologies GlobalMedical DevicesSEC FORM 4 Code M$379K60,000 at $6.32filing
5 Jun 2026filed 9 Jun 2026AVR Anteris Technologies GlobalMedical DevicesSEC FORM 4 Code F$389K39,595 at $9.83filing
5 Jun 2026filed 9 Jun 2026AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code M—2,001 at $0.00filing
5 Jun 2026filed 9 Jun 2026AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code M—60,000 at $0.00filing
5 Jun 2026filed 9 Jun 2026AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code M—2,001 at $0.00filing
5 Jun 2026filed 9 Jun 2026AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code M—60,000 at $0.00filing
5 Jun 2026filed 9 Jun 2026AVR Anteris Technologies GlobalMedical DevicesSEC FORM 4 Code M$9,6852,001 at $4.84filing
5 Jun 2026filed 9 Jun 2026AVR Anteris Technologies GlobalMedical DevicesSEC FORM 4 Code M$379K60,000 at $6.32filing
5 Jun 2026filed 9 Jun 2026AVR Anteris Technologies GlobalMedical DevicesSEC FORM 4 Code F$389K39,595 at $9.83filing
4 Mar 2026filed 6 Mar 2026AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code A—78,740 at $0.00filing
4 Mar 2026filed 6 Mar 2026AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code A—78,740 at $0.00filing
16 Dec 2025filed 18 Dec 2025AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code M—27,777 at $0.00filing
16 Dec 2025filed 18 Dec 2025AVR Anteris Technologies GlobalMedical DevicesSEC FORM 4 Code M—27,777filing
16 Dec 2024filed 18 Dec 2024AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code A—2,001 at $0.00filing
16 Dec 2024filed 18 Dec 2024AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code A—60,000 at $0.00filing
16 Dec 2024filed 18 Dec 2024AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code A—50,000 at $0.00filing
16 Dec 2024filed 18 Dec 2024AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code A—233,334 at $0.00filing
16 Dec 2024filed 18 Dec 2024AVR Anteris Technologies Globaloption or derivative · Medical DevicesSEC FORM 4 Code A—83,333 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

L1 Capital Pty Ltd10% owner · 10% owner at Anteris Technologies Global, filing Form 4 there in the last year
Brent MoenChief Financial Officer · Chief Financial Officer at Anteris Technologies Global, filing Form 4 there in the last year
David St DenisChief Operating Officer · Chief Operating Officer at Anteris Technologies Global, filing Form 4 there in the last year
David B. RobertsPresident and Director · Director at Anteris Technologies Global, filing Form 4 there in the last year
Gregory S. MossDirector · Director at Anteris Technologies Global, filing Form 4 there in the last year